JCR Pharmaceuticals (DB:JCR) - Stock Price, News & Analysis

JCR Stock Overview

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. More details

JCR fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	3/6
Past Performance	0/6
Financial Health	3/6
Dividends	3/6

Rewards

Trading at 18.6% below our estimate of its fair value

Earnings are forecast to grow 27.19% per year

Risk Analysis

Dividend of 2.71% is not well covered by earnings or free cash flows

JCR Pharmaceuticals Co., Ltd. Competitors

PharmaSGP Holding

XTRA:PSG

€309.3m

Dermapharm Holding

XTRA:DMP

€2.0b

Apontis Pharma

XTRA:APPH

€82.0m

Pierrel

DB:2FJ0

€92.8m

Price History & Performance

Summary of all time highs, changes and price drops for JCR Pharmaceuticals
Historical stock prices
Current Share Price	JP¥4.52
52 Week High	JP¥4.56
52 Week Low	JP¥3.80
Beta	0.027
11 Month Change	16.49%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	12.44%

Recent updates

Shareholder Returns

	JCR	DE Pharmaceuticals	DE Market
7D	18.9%	-0.3%	0.8%
1Y	n/a	-18.3%	8.6%

Return vs Industry: Insufficient data to determine how JCR performed against the German Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how JCR performed against the German Market.

Price Volatility

Is JCR's price volatile compared to industry and market?
JCR volatility
JCR Average Weekly Movement	5.3%
Pharmaceuticals Industry Average Movement	6.9%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: JCR has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine JCR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1975	934	Shin Ashida	www.jcrpharm.co.jp

JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease.

JCR Pharmaceuticals Co., Ltd. Fundamentals Summary

How do JCR Pharmaceuticals's earnings and revenue compare to its market cap?
JCR fundamental statistics
Market cap	€562.43m
Earnings (TTM)	-€2.74m
Revenue (TTM)	€220.85m

2.5x

P/S Ratio

-205.5x

P/E Ratio

Is JCR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JCR income statement (TTM)
Revenue	JP¥35.26b
Cost of Revenue	JP¥10.07b
Gross Profit	JP¥25.19b
Other Expenses	JP¥25.62b
Earnings	-JP¥437.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-3.59
Gross Margin	71.44%
Net Profit Margin	-1.24%
Debt/Equity Ratio	49.8%

How did JCR perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

-286%

Payout Ratio

Does JCR pay a reliable dividends?

See JCR dividend history and benchmarks

When do you need to buy JCR by to receive an upcoming dividend?
JCR Pharmaceuticals dividend dates
Ex Dividend Date	Sep 27 2024
Dividend Pay Date	Dec 06 2024
Days until Ex dividend	62 days
Days until Dividend pay date	8 days